Neukio Biotherapeutics Information
Contact top employees from
Neukio Biotherapeutics
Summary
Neukio Biotherapeutics focuses on development of next generation allogenic cell therapies via the iPSC-CAR-NK axis, through internal discovery and external collaboration, with emphasis on innovative i...Show more
Industries
Biotechnology
Headquarters Location
Employees Size
100-200 employees
Founded
2021
Employees Turnover 2 quarter 2025
Length of Employment
Employee tenure at Neukio Biotherapeutics shows a diverse range of experience levels:
25% for 1–2 years75% for 3–4 yearsContact top employees from
Neukio Biotherapeutics
Tingting Xu
Principal Scientist
Hongliang Zong
Vice President
